Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 367 entries
Sorted by: Best Match Show Resources per page
Lean body mass index prognostic value for cardiovascular events in patients with coronary artery disease.

Heart Asia

Hioki H, Miura T, Motoki H, Kobayashi H, Kobayashi M, Nakajima H, Kimura H, Mawatari E, Akanuma H, Sato T, Ebisawa S, Miyashita Y, Ikeda U, Hotta S, Kamiyoshi Y, Maruyama T, Watanabe N, Eisawa T, Aso S, Uchikawa S, Hashizume N, Sekimura N, Morita T.
PMID: 26345318
Heart Asia. 2015 Aug 26;7(2):12-18. doi: 10.1136/heartasia-2015-010644. eCollection 2015.

OBJECTIVE: Little is known about the relationship between body composition indicators, including body mass index (BMI), fat mass index (FMI) and lean BMI (LBMI), and adverse outcomes after percutaneous coronary intervention (PCI) in Asian populations. The aim of this...

Cite
Hioki H, Miura T, Motoki H, et al. Lean body mass index prognostic value for cardiovascular events in patients with coronary artery disease. Heart Asia. 2015;7(2):12-18doi: 10.1136/heartasia-2015-010644.
Hioki, H., Miura, T., Motoki, H., Kobayashi, H., Kobayashi, M., Nakajima, H., Kimura, H., Mawatari, E., Akanuma, H., Sato, T., Ebisawa, S., Miyashita, Y., Ikeda, U., Hotta, S., Kamiyoshi, Y., Maruyama, T., Watanabe, N., Eisawa, T., Aso, S., Uchikawa, S., Hashizume, N., Sekimura, N., & Morita, T. (2015). Lean body mass index prognostic value for cardiovascular events in patients with coronary artery disease. Heart Asia, 7(2), 12-18. https://doi.org/10.1136/heartasia-2015-010644
Hioki, Hirofumi, et al. "Lean body mass index prognostic value for cardiovascular events in patients with coronary artery disease." Heart Asia vol. 7,2 (2015): 12-18. doi: https://doi.org/10.1136/heartasia-2015-010644
Hioki H, Miura T, Motoki H, Kobayashi H, Kobayashi M, Nakajima H, Kimura H, Mawatari E, Akanuma H, Sato T, Ebisawa S, Miyashita Y, Ikeda U, Hotta S, Kamiyoshi Y, Maruyama T, Watanabe N, Eisawa T, Aso S, Uchikawa S, Hashizume N, Sekimura N, Morita T. Lean body mass index prognostic value for cardiovascular events in patients with coronary artery disease. Heart Asia. 2015 Aug 26;7(2):12-18. doi: 10.1136/heartasia-2015-010644. eCollection 2015. PMID: 26345318; PMCID: PMC4559317.
Copy Download .nbib Format: NLM
Platinum clusters with precise numbers of atoms for preparative-scale catalysis.

Nature communications

Imaoka T, Akanuma Y, Haruta N, Tsuchiya S, Ishihara K, Okayasu T, Chun WJ, Takahashi M, Yamamoto K.
PMID: 28947792
Nat Commun. 2017 Sep 25;8(1):688. doi: 10.1038/s41467-017-00800-4.

Subnanometer noble metal clusters have enormous potential, mainly for catalytic applications. Because a difference of only one atom may cause significant changes in their reactivity, a preparation method with atomic-level precision is essential. Although such a precision with enough...

Cite
Imaoka T, Akanuma Y, Haruta N, et al. Platinum clusters with precise numbers of atoms for preparative-scale catalysis. Nat Commun. 2017;8(1):688doi: 10.1038/s41467-017-00800-4.
Imaoka, T., Akanuma, Y., Haruta, N., Tsuchiya, S., Ishihara, K., Okayasu, T., Chun, W. J., Takahashi, M., & Yamamoto, K. (2017). Platinum clusters with precise numbers of atoms for preparative-scale catalysis. Nature communications, 8(1), 688. https://doi.org/10.1038/s41467-017-00800-4
Imaoka, Takane, et al. "Platinum clusters with precise numbers of atoms for preparative-scale catalysis." Nature communications vol. 8,1 (2017): 688. doi: https://doi.org/10.1038/s41467-017-00800-4
Imaoka T, Akanuma Y, Haruta N, Tsuchiya S, Ishihara K, Okayasu T, Chun WJ, Takahashi M, Yamamoto K. Platinum clusters with precise numbers of atoms for preparative-scale catalysis. Nat Commun. 2017 Sep 25;8(1):688. doi: 10.1038/s41467-017-00800-4. PMID: 28947792; PMCID: PMC5613004.
Copy Download .nbib Format: NLM
Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis.

Annals of surgical oncology

Yamamoto Y, Türkoğlu MA, Aramaki T, Sugiura T, Okamura Y, Ito T, Ashida R, Uemura S, Miyata T, Kato Y, Kakuta Y, Nakanuma Y, Uesaka K.
PMID: 27393571
Ann Surg Oncol. 2016 Aug;23:485-493. doi: 10.1245/s10434-016-5382-1. Epub 2016 Jul 08.

BACKGROUND: The indications for lymph node dissection (LND) for intrahepatic cholangiocarcinoma (ICC) are controversial.METHODS: Seventy patients with mass-forming dominant ICC underwent hepatectomy with systematic LND or lymph node sampling between 2003 and 2013. We defined the computed tomography (CT)...

Cite
Yamamoto Y, Türkoğlu MA, Aramaki T, et al. Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis. Ann Surg Oncol. 2016;23:485-493doi: 10.1245/s10434-016-5382-1.
Yamamoto, Y., Türkoğlu, M. A., Aramaki, T., Sugiura, T., Okamura, Y., Ito, T., Ashida, R., Uemura, S., Miyata, T., Kato, Y., Kakuta, Y., Nakanuma, Y., & Uesaka, K. (2016). Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis. Annals of surgical oncology, 23485-493. https://doi.org/10.1245/s10434-016-5382-1
Yamamoto, Yusuke, et al. "Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis." Annals of surgical oncology vol. 23 (2016): 485-493. doi: https://doi.org/10.1245/s10434-016-5382-1
Yamamoto Y, Türkoğlu MA, Aramaki T, Sugiura T, Okamura Y, Ito T, Ashida R, Uemura S, Miyata T, Kato Y, Kakuta Y, Nakanuma Y, Uesaka K. Vascularity of Intrahepatic Cholangiocarcinoma on Computed Tomography is Predictive of Lymph Node Metastasis. Ann Surg Oncol. 2016 Aug;23:485-493. doi: 10.1245/s10434-016-5382-1. Epub 2016 Jul 08. PMID: 27393571.
Copy Download .nbib Format: NLM
Monocrotaline-induced pulmonary hypertension with sufficient tricuspid regurgitation in a rat model.

Journal of medical ultrasonics (2001)

Ishikura F, Azakami R, Asanuma T, Beppu S.
PMID: 27279108
J Med Ultrason (2001). 2012 Oct;39(4):221-6. doi: 10.1007/s10396-012-0371-x. Epub 2012 May 24.

BACKGROUND AND PURPOSE: It is well known that monocrotaline (MCT) induces pulmonary hypertension (PH) in rats. This model is very useful for understanding the physiology of PH and developing treatments for PH. However, it is very difficult to estimate...

Cite
Ishikura F, Azakami R, Asanuma T, et al. Monocrotaline-induced pulmonary hypertension with sufficient tricuspid regurgitation in a rat model. J Med Ultrason (2001). 2012;39(4):221-6doi: 10.1007/s10396-012-0371-x.
Ishikura, F., Azakami, R., Asanuma, T., & Beppu, S. (2012). Monocrotaline-induced pulmonary hypertension with sufficient tricuspid regurgitation in a rat model. Journal of medical ultrasonics (2001), 39(4), 221-6. https://doi.org/10.1007/s10396-012-0371-x
Ishikura, Fuminobu, et al. "Monocrotaline-induced pulmonary hypertension with sufficient tricuspid regurgitation in a rat model." Journal of medical ultrasonics (2001) vol. 39,4 (2012): 221-6. doi: https://doi.org/10.1007/s10396-012-0371-x
Ishikura F, Azakami R, Asanuma T, Beppu S. Monocrotaline-induced pulmonary hypertension with sufficient tricuspid regurgitation in a rat model. J Med Ultrason (2001). 2012 Oct;39(4):221-6. doi: 10.1007/s10396-012-0371-x. Epub 2012 May 24. PMID: 27279108.
Copy Download .nbib Format: NLM
A Case of Hypereosinophilia-Associated Multiple Mass Lesions of Liver Showing Non-Granulomatous Eosinophilic Hepatic Necrosis.

Gastroenterology research

Ikeda H, Katayanagi K, Kurumaya H, Harada K, Sato Y, Sasaki M, Nakanuma Y.
PMID: 27942335
Gastroenterology Res. 2011 Aug;4(4):168-173. doi: 10.4021/gr336e. Epub 2011 Jul 20.

Hypereosinophilic syndrome (HES) is defined by elevation more than 1.5×10

Cite
Ikeda H, Katayanagi K, Kurumaya H, et al. A Case of Hypereosinophilia-Associated Multiple Mass Lesions of Liver Showing Non-Granulomatous Eosinophilic Hepatic Necrosis. Gastroenterology Res. 2011;4(4):168-173doi: 10.4021/gr336e.
Ikeda, H., Katayanagi, K., Kurumaya, H., Harada, K., Sato, Y., Sasaki, M., & Nakanuma, Y. (2011). A Case of Hypereosinophilia-Associated Multiple Mass Lesions of Liver Showing Non-Granulomatous Eosinophilic Hepatic Necrosis. Gastroenterology research, 4(4), 168-173. https://doi.org/10.4021/gr336e
Ikeda, Hiroko, et al. "A Case of Hypereosinophilia-Associated Multiple Mass Lesions of Liver Showing Non-Granulomatous Eosinophilic Hepatic Necrosis." Gastroenterology research vol. 4,4 (2011): 168-173. doi: https://doi.org/10.4021/gr336e
Ikeda H, Katayanagi K, Kurumaya H, Harada K, Sato Y, Sasaki M, Nakanuma Y. A Case of Hypereosinophilia-Associated Multiple Mass Lesions of Liver Showing Non-Granulomatous Eosinophilic Hepatic Necrosis. Gastroenterology Res. 2011 Aug;4(4):168-173. doi: 10.4021/gr336e. Epub 2011 Jul 20. PMID: 27942335; PMCID: PMC5139729.
Copy Download .nbib Format: NLM
Cystic and Papillary Neoplasm at the Hepatic Hilum Possibly Originating in the Peribiliary Glands.

Case reports in pathology

Miyata T, Uesaka K, Nakanuma Y.
PMID: 27656307
Case Rep Pathol. 2016;2016:9130754. doi: 10.1155/2016/9130754. Epub 2016 Aug 31.

Cystic neoplasms of the liver are divided into two types: mucinous cystic neoplasm and cystic intraductal papillary neoplasm of the bile duct. We herein report two cases of cystic and papillary neoplasm of the liver which differed from the...

Cite
Miyata T, Uesaka K, Nakanuma Y. Cystic and Papillary Neoplasm at the Hepatic Hilum Possibly Originating in the Peribiliary Glands. Case Rep Pathol. 2016;2016:9130754doi: 10.1155/2016/9130754.
Miyata, T., Uesaka, K., & Nakanuma, Y. (2016). Cystic and Papillary Neoplasm at the Hepatic Hilum Possibly Originating in the Peribiliary Glands. Case reports in pathology, 20169130754. https://doi.org/10.1155/2016/9130754
Miyata, Takashi, et al. "Cystic and Papillary Neoplasm at the Hepatic Hilum Possibly Originating in the Peribiliary Glands." Case reports in pathology vol. 2016 (2016): 9130754. doi: https://doi.org/10.1155/2016/9130754
Miyata T, Uesaka K, Nakanuma Y. Cystic and Papillary Neoplasm at the Hepatic Hilum Possibly Originating in the Peribiliary Glands. Case Rep Pathol. 2016;2016:9130754. doi: 10.1155/2016/9130754. Epub 2016 Aug 31. PMID: 27656307; PMCID: PMC5021872.
Copy Download .nbib Format: NLM
Corrigendum to "Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson's disease" [Brain Behav. Immun. 51 (2016) 39-46].

Brain, behavior, and immunity

Sugama S, Sekiyama K, Kodama T, Takamatsu Y, Takenouchi T, Hashimoto M, Conti B, Kakinuma Y.
PMID: 28040434
Brain Behav Immun. 2017 Mar;61:389. doi: 10.1016/j.bbi.2016.12.009. Epub 2016 Dec 28.

No abstract available.

Cite
Sugama S, Sekiyama K, Kodama T, et al. Corrigendum to "Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson's disease" [Brain Behav. Immun. 51 (2016) 39-46]. Brain Behav Immun. 2016;61:389doi: 10.1016/j.bbi.2016.12.009.
Sugama, S., Sekiyama, K., Kodama, T., Takamatsu, Y., Takenouchi, T., Hashimoto, M., Conti, B., & Kakinuma, Y. (2017). Corrigendum to "Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson's disease" [Brain Behav. Immun. 51 (2016) 39-46]. Brain, behavior, and immunity, 61389. https://doi.org/10.1016/j.bbi.2016.12.009
Sugama, Shuei, et al. "Corrigendum to "Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson's disease" [Brain Behav. Immun. 51 (2016) 39-46]." Brain, behavior, and immunity vol. 61 (2017): 389. doi: https://doi.org/10.1016/j.bbi.2016.12.009
Sugama S, Sekiyama K, Kodama T, Takamatsu Y, Takenouchi T, Hashimoto M, Conti B, Kakinuma Y. Corrigendum to "Chronic restraint stress triggers dopaminergic and noradrenergic neurodegeneration: Possible role of chronic stress in the onset of Parkinson's disease" [Brain Behav. Immun. 51 (2016) 39-46]. Brain Behav Immun. 2017 Mar;61:389. doi: 10.1016/j.bbi.2016.12.009. Epub 2016 Dec 28. PMID: 28040434; PMCID: PMC5554705.
Copy Download .nbib Format: NLM
Targeting interleukin-4 receptor alpha by hybrid Peptide for novel biliary tract cancer therapy.

International journal of hepatology

Seto K, Shoda J, Horibe T, Warabi E, Kohno M, Yanagawa T, Bukawa H, Nakanuma Y, Kawakami K.
PMID: 24868471
Int J Hepatol. 2014;2014:584650. doi: 10.1155/2014/584650. Epub 2014 Apr 27.

It is known that the interleukin-4 receptor α (IL-4R α ) is highly expressed on the surface of various human solid tumors. We previously designed novel IL-4R α -lytic hybrid peptide composed of binding peptide to IL-4R α and...

Cite
Seto K, Shoda J, Horibe T, et al. Targeting interleukin-4 receptor alpha by hybrid Peptide for novel biliary tract cancer therapy. Int J Hepatol. 2014;2014:584650doi: 10.1155/2014/584650.
Seto, K., Shoda, J., Horibe, T., Warabi, E., Kohno, M., Yanagawa, T., Bukawa, H., Nakanuma, Y., & Kawakami, K. (2014). Targeting interleukin-4 receptor alpha by hybrid Peptide for novel biliary tract cancer therapy. International journal of hepatology, 2014584650. https://doi.org/10.1155/2014/584650
Seto, Kahori, et al. "Targeting interleukin-4 receptor alpha by hybrid Peptide for novel biliary tract cancer therapy." International journal of hepatology vol. 2014 (2014): 584650. doi: https://doi.org/10.1155/2014/584650
Seto K, Shoda J, Horibe T, Warabi E, Kohno M, Yanagawa T, Bukawa H, Nakanuma Y, Kawakami K. Targeting interleukin-4 receptor alpha by hybrid Peptide for novel biliary tract cancer therapy. Int J Hepatol. 2014;2014:584650. doi: 10.1155/2014/584650. Epub 2014 Apr 27. PMID: 24868471; PMCID: PMC4020457.
Copy Download .nbib Format: NLM
Clinical characteristics of patients with large and deep soft tissue sarcomas.

Oncology letters

Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A.
PMID: 26622580
Oncol Lett. 2015 Aug;10(2):841-844. doi: 10.3892/ol.2015.3289. Epub 2015 May 28.

In the present study, the incidence of surgical wound complications in patients with large and deep high-grade soft tissue sarcoma (STS) was investigated. In addition, the disease-specific and event-free survival rates were examined in these patients. In total, 30...

Cite
Nakamura T, Matsumine A, Matsubara T, et al. Clinical characteristics of patients with large and deep soft tissue sarcomas. Oncol Lett. 2015;10(2):841-844doi: 10.3892/ol.2015.3289.
Nakamura, T., Matsumine, A., Matsubara, T., Asanuma, K., Uchida, A., & Sudo, A. (2015). Clinical characteristics of patients with large and deep soft tissue sarcomas. Oncology letters, 10(2), 841-844. https://doi.org/10.3892/ol.2015.3289
Nakamura, Tomoki, et al. "Clinical characteristics of patients with large and deep soft tissue sarcomas." Oncology letters vol. 10,2 (2015): 841-844. doi: https://doi.org/10.3892/ol.2015.3289
Nakamura T, Matsumine A, Matsubara T, Asanuma K, Uchida A, Sudo A. Clinical characteristics of patients with large and deep soft tissue sarcomas. Oncol Lett. 2015 Aug;10(2):841-844. doi: 10.3892/ol.2015.3289. Epub 2015 May 28. PMID: 26622580; PMCID: PMC4509109.
Copy Download .nbib Format: NLM
Endoscopic treatment of tracheoesophageal fistula using the over-the-scope-clip system.

Annals of gastroenterology

Matsui S, Kashida H, Asakuma Y, Kudo M.
PMID: 28845115
Ann Gastroenterol. 2017;30(5):578. doi: 10.20524/aog.2017.0181. Epub 2017 Jul 26.

No abstract available.

Cite
Matsui S, Kashida H, Asakuma Y, et al. Endoscopic treatment of tracheoesophageal fistula using the over-the-scope-clip system. Ann Gastroenterol. 2017;30(5):578doi: 10.20524/aog.2017.0181.
Matsui, S., Kashida, H., Asakuma, Y., & Kudo, M. (2017). Endoscopic treatment of tracheoesophageal fistula using the over-the-scope-clip system. Annals of gastroenterology, 30(5), 578. https://doi.org/10.20524/aog.2017.0181
Matsui, Shigenaga, et al. "Endoscopic treatment of tracheoesophageal fistula using the over-the-scope-clip system." Annals of gastroenterology vol. 30,5 (2017): 578. doi: https://doi.org/10.20524/aog.2017.0181
Matsui S, Kashida H, Asakuma Y, Kudo M. Endoscopic treatment of tracheoesophageal fistula using the over-the-scope-clip system. Ann Gastroenterol. 2017;30(5):578. doi: 10.20524/aog.2017.0181. Epub 2017 Jul 26. PMID: 28845115; PMCID: PMC5566780.
Copy Download .nbib Format: NLM
Histological Characterization of Biliary Intraepithelial Neoplasia with respect to Pancreatic Intraepithelial Neoplasia.

International journal of hepatology

Sato Y, Harada K, Sasaki M, Nakanuma Y.
PMID: 24860672
Int J Hepatol. 2014;2014:678260. doi: 10.1155/2014/678260. Epub 2014 Apr 10.

Biliary intraepithelial neoplasia (BilIN) is a precursor lesion of hilar/perihilar and extrahepatic cholangiocarcinoma. BilIN represents the process of multistep cholangiocarcinogenesis and is the biliary counterpart of pancreatic intraepithelial neoplasia (PanIN). This study was performed to clarify the histological characteristics...

Cite
Sato Y, Harada K, Sasaki M, et al. Histological Characterization of Biliary Intraepithelial Neoplasia with respect to Pancreatic Intraepithelial Neoplasia. Int J Hepatol. 2014;2014:678260doi: 10.1155/2014/678260.
Sato, Y., Harada, K., Sasaki, M., & Nakanuma, Y. (2014). Histological Characterization of Biliary Intraepithelial Neoplasia with respect to Pancreatic Intraepithelial Neoplasia. International journal of hepatology, 2014678260. https://doi.org/10.1155/2014/678260
Sato, Yasunori, et al. "Histological Characterization of Biliary Intraepithelial Neoplasia with respect to Pancreatic Intraepithelial Neoplasia." International journal of hepatology vol. 2014 (2014): 678260. doi: https://doi.org/10.1155/2014/678260
Sato Y, Harada K, Sasaki M, Nakanuma Y. Histological Characterization of Biliary Intraepithelial Neoplasia with respect to Pancreatic Intraepithelial Neoplasia. Int J Hepatol. 2014;2014:678260. doi: 10.1155/2014/678260. Epub 2014 Apr 10. PMID: 24860672; PMCID: PMC4003763.
Copy Download .nbib Format: NLM
Evaluation of left ventricular rotation by two-dimensional speckle tracking method and real-time three-dimensional echocardiography: comparison with MRI tagging method.

Journal of echocardiography

Hayashi H, Izumi C, Takahashi S, Uchikoshi M, Yamazaki R, Asanuma T, Ishikura F, Beppu S, Nakatani S.
PMID: 27277174
J Echocardiogr. 2011 Sep;9(3):83-9. doi: 10.1007/s12574-010-0077-2. Epub 2010 Dec 15.

BACKGROUND: Recently, it has become possible to evaluate left ventricular (LV) torsion by two-dimensional (2D) speckle tracking images. However, LV torsion is a three-dimensional (3D) performance, which per se cannot be assessed by the 2D speckle tracking method. The...

Cite
Hayashi H, Izumi C, Takahashi S, et al. Evaluation of left ventricular rotation by two-dimensional speckle tracking method and real-time three-dimensional echocardiography: comparison with MRI tagging method. J Echocardiogr. 2010;9(3):83-9doi: 10.1007/s12574-010-0077-2.
Hayashi, H., Izumi, C., Takahashi, S., Uchikoshi, M., Yamazaki, R., Asanuma, T., Ishikura, F., Beppu, S., & Nakatani, S. (2011). Evaluation of left ventricular rotation by two-dimensional speckle tracking method and real-time three-dimensional echocardiography: comparison with MRI tagging method. Journal of echocardiography, 9(3), 83-9. https://doi.org/10.1007/s12574-010-0077-2
Hayashi, Hidetaka, et al. "Evaluation of left ventricular rotation by two-dimensional speckle tracking method and real-time three-dimensional echocardiography: comparison with MRI tagging method." Journal of echocardiography vol. 9,3 (2011): 83-9. doi: https://doi.org/10.1007/s12574-010-0077-2
Hayashi H, Izumi C, Takahashi S, Uchikoshi M, Yamazaki R, Asanuma T, Ishikura F, Beppu S, Nakatani S. Evaluation of left ventricular rotation by two-dimensional speckle tracking method and real-time three-dimensional echocardiography: comparison with MRI tagging method. J Echocardiogr. 2011 Sep;9(3):83-9. doi: 10.1007/s12574-010-0077-2. Epub 2010 Dec 15. PMID: 27277174.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 367 entries